Zhu H, Xue H, Wang H, Chen Y, Zhou S, Tian F, Hu S, Wang J, Yang J, Zhang T
Department of Cardiology, General Hospital of PLA, Beijing, China -
Minerva Cardioangiol. 2015 Jun;63(3):171-8. Epub 2014 Dec 11.
The aim of this paper was to investigate the value of Global Registry of Acute Coronary Events (GRACE) and thrombolysis in myocardial infarction (TIMI) risk scores for risk stratification and prognosis in female patients with non-ST segment elevation acute coronary syndrome (NSTE-ACS).
Non-elderly (<65 years) and elderly (≥65 years) female patients with NSTE-ACS (totally 869 cases) were enrolled in this study. The patients were further divided into low, intermediate and high-risk groups according to their GRACE and TIMI scores. Patients were followed up for 1 year to record the mortality and incidence of major adverse cardiac events (MACE). Differences in mortality and MACE incidence between the two scoring systems were compared by the area under the ROC curve.
The area under ROC curve (AUC) corresponding to the mortality and MACE incidence in any period by the GRACE scoring system was significantly larger than the TIMI scoring system in the elderly patients at 1 year of follow-up (AUC of mortality, 0.79 vs. 0.68; AUC of MACE, 0.78 vs. 0.72; P<0.05). Mortality and MACE incidence increased in parallel with the scores. Risk ratio values of Cox regression analysis based on GRACE and TIMI scores were greater than 1 (P<0.001).
Both GRACE and TIMI were adoptable in clinical risk stratification and prognosis of female patients with NSTE-ACS at different age groups. GRACE showed better accuracy than the TIMI scores.
本文旨在探讨全球急性冠状动脉事件注册研究(GRACE)和心肌梗死溶栓治疗(TIMI)风险评分在非ST段抬高型急性冠状动脉综合征(NSTE-ACS)女性患者风险分层及预后评估中的价值。
本研究纳入了非老年(<65岁)和老年(≥65岁)的NSTE-ACS女性患者共869例。根据GRACE和TIMI评分将患者进一步分为低、中、高危组。对患者进行1年随访,记录死亡率和主要不良心脏事件(MACE)的发生率。通过ROC曲线下面积比较两种评分系统在死亡率和MACE发生率方面的差异。
在随访1年时,老年患者中GRACE评分系统对应任何时期死亡率和MACE发生率的ROC曲线下面积(AUC)均显著大于TIMI评分系统(死亡率AUC:0.79对0.68;MACE的AUC:0.78对0.72;P<0.05)。死亡率和MACE发生率随评分升高而平行增加。基于GRACE和TIMI评分的Cox回归分析风险比值均大于1(P<0.001)。
GRACE和TIMI评分均可用于不同年龄组NSTE-ACS女性患者的临床风险分层和预后评估。GRACE评分的准确性优于TIMI评分。